NRIX short interest
Nurix Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 17,657,588 |
|---|---|
| Change vs prior report | -319,216 (-1.8%) |
| Change over six months | -2.6% |
| Days to cover | 9.94 (sector: 3.78) |
| Average daily volume | 1,776,243 |
| Rank in Healthcare | #111 of 922 by days to cover |
NRIX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 17,657,588 | -1.8% | 9.94 | 1,776,243 |
| 2026-09-15 | 17,976,804 | +0.1% | 14.05 | 1,279,919 |
| 2026-08-31 | 17,950,461 | -0.2% | 15.94 | 1,126,118 |
| 2026-08-14 | 17,984,342 | -2.0% | 18.11 | 993,103 |
| 2026-07-31 | 18,351,438 | +2.1% | 17.99 | 1,019,972 |
| 2026-07-15 | 17,979,165 | +1.0% | 13.87 | 1,296,203 |
| 2026-06-30 | 17,798,300 | -11.1% | 5.43 | 3,279,006 |
| 2026-06-15 | 20,024,913 | +3.6% | 4.94 | 4,050,135 |
| 2026-05-29 | 19,321,862 | +3.7% | 14.88 | 1,298,393 |
| 2026-05-15 | 18,633,310 | -3.0% | 22.21 | 838,931 |
| 2026-04-30 | 19,201,109 | +0.0% | 24.33 | 789,342 |
| 2026-04-15 | 19,201,724 | +5.9% | 14.08 | 1,364,154 |
| 2026-03-31 | 18,130,036 | +12.1% | 11.55 | 1,569,882 |
| 2026-03-13 | 16,178,402 | +1.3% | 19.61 | 825,157 |
| 2026-02-27 | 15,971,376 | +4.7% | 20.29 | 787,247 |
| 2026-02-13 | 15,248,252 | +1.9% | 17.99 | 847,584 |
| 2026-01-30 | 14,961,980 | -1.6% | 11.72 | 1,276,463 |
| 2026-01-15 | 15,197,058 | +3.8% | 11.01 | 1,380,737 |
| 2025-12-31 | 14,644,521 | +7.3% | 9.39 | 1,559,025 |
| 2025-12-15 | 13,642,687 | -5.8% | 6.18 | 2,207,900 |
| 2025-11-28 | 14,487,622 | +2.9% | 9.10 | 1,591,416 |
| 2025-11-14 | 14,076,725 | +7.3% | 9.58 | 1,468,931 |
| 2025-10-31 | 13,118,235 | -5.4% | 6.03 | 2,176,479 |
| 2025-10-15 | 13,868,490 | +6.4% | 9.80 | 1,415,573 |
| 2025-09-30 | 13,035,274 | -0.1% | 11.10 | 1,174,571 |
import finzdata as yf
yf.Ticker("NRIX").short_interest # every report since 2017
yf.Client().short_interest(["NRIX"], start="2018-01-01")Healthcare short interest · NRIX price history · Who owns NRIX · All short interest